Poster Abstract Session:
232. Clostridium difficile: Risk Factors
Saturday, October 29, 2016: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:

.

Tracks: Epidemiology and Infection Control, Adult ID

Presentations:
2100
Predictive Factors of Clostridium difficile Infection in Hospital Inpatients
Koray Demir, MDCM Candidate ; Matthew Pellan Cheng, M.D., C.M. ; Todd C. Lee, MD, MPH
2101
Fulminant colitis in hospital onset Clostridium difficile infection (CDI): incidence, trend, and risk factors
Ruihong Luo, MD, PhD ; Christian Stone, MD, MPH
Posters
  • Fulminant C diff colitis 10-17-2016.pdf (252.4 kB)
    • 2102
    Testing Is Only Part Of The Story: identifying risk factors for C. Difficile Colonization diagnosed during inpatient admission
    Michele Yeung, MD ; Daniel Luger, MD ; Marcelo Mendez, MD ; Marie Moss, RN, MPH, CIC ; Dana Mazo, MD, MSc ; Dahlia Rizk, DO, MPH
    Posters
  • Cdiff IDWeek Poster 2102.pdf (399.0 kB)
    • 2103
    Efficacy of Computed Tomography for the Prediction of Colectomy and Mortality in Patients with Clostridium difficile InfectionEfficacy of Computed Tomography for the Prediction of Colectomy and Mortality in Patients with Clostridium difficile Infection
    Laura Paláu-Dávila, M.D. ; Reynaldo Lara-Medrano, M.D. ; Adrián Negreros-Osuna, M.D. ; Matías Salinas-Chapa, M.D. ; Elvira Garza-Gonzalez, PhD ; Eva Gutiérrez-Delgado, M.D. ; Adrian Camacho-Ortiz, M.D., PhD
    Posters
  • Clostridiumtac.pdf (987.9 kB)
    • 2104
    Observational Study of Risk factors for Clostridium difficile Infection in Hospitalised Patients with Infective Diarrhoea (ORCHID): Consistency of Risk Factors
    Kerrie Davies, MSc ; Jody Lawrence, MD ; Claire Berry, MSc ; Georgina Davis, BSc ; Holly Yu, MSPH ; Bing Cai, PhD ; Elisa Gonzalez, MSc ; Ida Prantner, MD ; Andrea Kurcz, MD ; Ioana Macovei, MSc ; Hanna Pituch, PhD ; Elena Novakova, MD PhD ; Otakar Nyc, MD PhD ; Mathias Herrmann, MD ; Fabian Berger, MD ; Oliver Cornely, MD, FACP, FIDSA, FAAM ; Maria Vehreschild, MD ; Louise Pedneault, MD Msc FRCPC ; Mark Wilcox, MD
    Posters
  • Poster for ID week 2016.pdf (459.1 kB)
    • 2105
    Epidemiological Assessment of the Association Between Antibiotic Consumption and Clostridium difficile Incidence at an Academic Medical Center
    Page Crew, PharmD, MPH, BCPS ; Nathaniel Rhodes, PharmD, MSc ; J. Nicholas O'donnell, PharmD ; Cristina Miglis, PharmD, BCPS ; Elise Gilbert, PharmD, BCPS ; Teresa Zembower, MD, MPH, FIDSA ; Chao Qi, PhD ; Christina Silkaitis, MT (ASCP), CIC ; Sarah Sutton, MD ; Marc Scheetz, PharmD, MSc, BCPS AQ-ID
    Posters
  • 2105_PCrew IDweek 2016.pdf (1.3 MB)
    • 2106
    Antibiotic Exposure after Clostridium difficile infection (CDI) diagnosis in Pediatric Oncology Patients.
    Elizabeth Robilotti, MD MPH ; Nina Cohen, PharmD ; Mini Kamboj, MD ; Susan Seo, MD, FIDSA
    2107
    Integrating Prior Healthcare Exposure into National Mandatory Clostridium difficile Infection Surveillance
    John Davies, MPH ; Sarah Gerver, PhD ; Alan Johnson, PhD ; Mark Wilcox, MD ; Russell Hope, PhD
    Posters
  • CDI_PriorHCExposure_2107.pdf (633.2 kB)
    • 2108
    Receipt of antibiotics in hospitalized patients increases risk for Clostridium difficile infection in future patients who occupy the same bed
    Daniel Freedberg, MD, MS ; Hojjat Salmasian, MD, PhD ; Bevin Cohen, MPH, MPhil ; Julian Abrams, MD, MS ; Elaine Larson, RN, PhD
    Posters
  • Prior_patient.pdf (683.5 kB)

    • CME Credits: No CME credit is offered for this session.

    ACPE Credits:

    ACPE Number:


    See more of: Poster Abstract Session
    << Previous Session | Next Session >>

    Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.